title: Small company mergers--good for whom?
abstract: An analysis of 105 mergers among small UK biotech companies over a 10-year period shows that the improvement of shareholder positions, rather than product pipelines or business opportunities, is the main motivation for such transactions.
authors.affiliation: Röper Laboratory, The Wellcome Trust-Cancer Research UK, Gurdon Institute of Cancer and Developmental Biology, Tennis Court Road, Cambridge CB2 1QN, UK.
authors.forename: Vanessa
authors.initials: V
authors.lastname: Maybeck
authors.forename: William
authors.initials: W
authors.lastname: Bains
mesh_terms: D001709:Biotechnology / Q000191:economics* / Q000458:organization & administration* / Q000639:trends; D019981:Health Care Sector / Q000458:organization & administration*; D007449:Investments / Q000191:economics* / Q000639:trends; D017059:Models, Econometric; D009935:Organizational Affiliation; D010067:Ownership; D006113:United Kingdom